Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
shortfill; reports of empty capsules.
| Recalling firm | Aurobindo Pharma USA Inc |
|---|---|
| Reason | shortfill; reports of empty capsules. |
| Risk class | Class II (Class II · moderate) |
| Status | Ongoing |
| Report date | Aug 12, 2026 |
| Initiated | Jul 23, 2026 |
| Region | NJ, United States |
| Distribution | US Nationwide. |
| Quantity | 6,408 bottles distributed to market |
| Code/Lot | Batch # DMC125018A, Exp Date: 07/2027. |
| Type | Voluntary: Firm initiated |
| Recall number | D-0733-2026 |
Official source
U.S. FDA — Recalls, Market Withdrawals & Safety Alerts fda.gov ↗You can re-verify each item on the official FDA site using its recall number. (Recall number: D-0733-2026)
openFDA (U.S. Food & Drug Administration) — food/drug/device enforcement · CC0 1.0 (public domain)
Find out more
- Search this recall on FDA fda.gov ↗
- Search related news (Google News) news.google.com ↗
- Search this product (Google) google.com ↗
The links above open external searches by recall number / product name; the results are the responsibility of each site.
This page summarizes U.S. FDA data for general information and is not medical advice. Confirm details via official FDA announcements and the manufacturer.